Assets تغيير تاريخ
Acadia Pharmaceuticals USD 748.96M 116.42M 2023-12
Agios Pharmaceuticals USD 937.12M 70.14M 2023-12
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
Amgen USD 97.15B 6.62B 2023-12
Arrowhead Research USD 626.29M 139.27M 2023-12
Avrobio USD 110.52M 23.31M 2023-09
BioCryst Pharmaceuticals USD 522.92M 6.96M 2023-09
BioMarin Pharmaceutical USD 6.84B 83.44M 2023-12
Bluebird Bio USD 613.61M 49.78M 2023-09
Incyte USD 6.78B 393.87M 2023-12
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
Moderna USD 18.43B 1.02B 2023-12
Neurocrine Biosciences USD 2.85B 235.1M 2023-09
PTC Therapeutics USD 1.9B 635.81M 2023-12
Regeneron Pharmaceuticals USD 33.08B 916.9M 2023-12
Regulus Therapeutics USD 37.75M 5.9M 2023-09
Sarepta Therapeutics USD 3.11B 16.18M 2023-09
Takeda JPY 14.87T 79.15B 2023-09
Ultragenyx Pharmaceutical USD 1.49B 252.87M 2023-12
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09
Xencor USD 952.69M 174.26M 2023-12



Alnylam Pharmaceuticals الأصول - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2024.